Form 4: Vigil Neuroscience Director Bruce Booth Acquires Stock Options

Director Bruce Booth of Vigil Neuroscience, Inc. was granted stock options for 18,068 shares on June 5, 2024, under the company's 2021 Stock Option and Incentive Plan.

Summary

• On June 5, 2024, Bruce Booth, a director of Vigil Neuroscience, Inc., was granted stock options for 18,068 shares.
• The options were awarded under the Issuer's 2021 Stock Option and Incentive Plan.
• The exercise price of the options is $3.38 per share.
• The options vest and become exercisable on the earlier of June 5, 2025, or the next annual meeting of the Issuer's stockholders.
• The options expire on June 5, 2034.
• Booth disclaims beneficial ownership of the securities, except to the extent of his pecuniary interest, as he is obligated to transfer any economic benefit from the sale of shares to Atlas Venture Life Science Advisors, LLC.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (stock option grant) and doesn't contain any alarming or negative information. It's a neutral event with a slightly positive implication for aligning director incentives.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes long-term commitment from the director.

Industry Context

This is a standard practice for compensating directors and aligning their interests with shareholders in biotech companies.

Comparison to Industry Standards

• Stock option grants are a common form of compensation for directors in publicly traded companies, particularly in the biotechnology sector.
• The vesting schedule and exercise price are typical for such grants.
• Companies like Biogen and Amgen also use stock options as part of their director compensation packages.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of the shareholders, potentially leading to better decision-making.
• There is no immediate impact on employees, customers, suppliers, or creditors.

Key Dates